Hatim R. Husain

Oncology

2020 Zonal Ave
Los Angeles, CA 90089

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Erratum: Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 08, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 03, 2026

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 03, 2026

Single-cell and spatial analysis reveals macrophage-T cell crosstalk in non-small cell lung cancer immunosuppression.

Single-cell and spatial analysis reveals macrophage-T cell crosstalk in non-small cell lung cancer immunosuppression.

Journal: Translational lung cancer research

Published: August 05, 2025

Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer.

Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer.

Journal: Cancer treatment reviews

Published: May 01, 2025

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024.

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024.

Journal: Cancer

Published: April 28, 2025

Regulation of lung cancer initiation and progression by the stem cell determinant Musashi.

Regulation of lung cancer initiation and progression by the stem cell determinant Musashi.

Journal: eLife

Published: March 06, 2025

Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring.

Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring.

Journal: Scientific reports

Published: December 27, 2024

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.

Journal: Frontiers in oncology

Published: July 30, 2024

Brief Report: Methylation-Based ctDNA Serial Monitoring Correlates With Immunotherapy Response in NSCLC.

Brief Report: Methylation-Based ctDNA Serial Monitoring Correlates With Immunotherapy Response in NSCLC.

Journal: Clinical lung cancer

Published: July 08, 2024

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment.

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment.

Journal: NPJ precision oncology

Published: June 23, 2024

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study.

Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study.

Journal: Translational lung cancer research

Published: April 27, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026